We are live on ! Find out more
CVS icon

CVS Health

1,844 hedge funds and large institutions have $75.3B invested in CVS Health in 2019 Q4 according to their latest regulatory filings, with 255 funds opening new positions, 723 increasing their positions, 709 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

249% more first-time investments, than exits

New positions opened: 255 | Existing positions closed: 73

32% more call options, than puts

Call options by funds: $2.15B | Put options by funds: $1.63B

18% more capital invested

Capital invested by funds: $63.9B → $75.3B (+$11.5B)

15% more funds holding in top 10

Funds holding in top 10: 8497 (+13)

10% more funds holding

Funds holding: 1,6841,844 (+160)

2% more repeat investments, than reductions

Existing positions increased: 723 | Existing positions reduced: 709

0.04% more ownership

Funds ownership: 77.95%77.99% (+0.04%)

Holders
1,844
Holders Change
+160
Holders Change %
+9.5%
% of All Funds
36.33%
Holding in Top 10
97
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+15.48%
% of All Funds
1.91%
New
255
Increased
723
Reduced
709
Closed
73
Calls
$2.15B
Puts
$1.63B
Net Calls
+$524M
Net Calls Change
+$375M
Name Holding Trade Value Shares
Change
Change in
Stake
FAM
1001
Formidable Asset Management
Ohio
$1.44M +$1.35M +19,246 New
BCP
1002
Berkeley Capital Partners
Georgia
$1.43M -$87.9K -1,252 -6%
HIS
1003
Horizon Investment Services
Indiana
$1.43M +$1.35M +19,252 New
YMRC
1004
Yorktown Management & Research Company
Virginia
$1.43M
BIM
1005
Baldwin Investment Management
Pennsylvania
$1.43M +$7.02K +100 +0.5%
CBN
1006
Cadence Bank NA
Texas
$1.42M +$60.7K +864 +5%
SMC
1007
Smith, Moore & Co
Missouri
$1.42M -$109K -1,551 -8%
PA
1008
Parallel Advisors
California
$1.41M +$76.7K +1,092 +6%
FMTCOCP
1009
Farmers & Merchants Trust Co of Chambersburg PA
Pennsylvania
$1.4M +$44.2K +630 +3%
IDBONY
1010
Israel Discount Bank of New York
New York
$1.39M +$125K +1,774 +10%
CMANY
1011
Capital Management Associates (New York)
New York
$1.39M -$913K -13,000 -41%
BG
1012
Bollard Group
Massachusetts
$1.38M +$1.48K +21 +0.1%
FIM
1013
Freedom Investment Management
Connecticut
$1.38M +$273K +3,886 +26%
HT
1014
Heritage Trust
Oklahoma
$1.38M -$214K -3,044 -14%
ACC
1015
Accident Compensation Corp
New Zealand
$1.38M
GCC
1016
Guardian Capital (Canada)
Ontario, Canada
$1.37M +$253K +3,600 +24%
CIP
1017
Convergence Investment Partners
Florida
$1.36M +$818K +11,644 +175%
HAG
1018
HighPoint Advisor Group
Illinois
$1.36M +$33.4K +475 +3%
FHC
1019
First Heartland Consultants
Missouri
$1.36M -$665K -9,469 -34%
HC
1020
HNP Capital
New York
$1.36M +$637K +9,074 +93%
WCA
1021
Westover Capital Advisors
Delaware
$1.35M +$210K +2,984 +20%
1WA
1022
180 Wealth Advisors
Washington
$1.35M +$132K +1,883 +12%
FC
1023
FORA Capital
Florida
$1.35M +$1.27M +18,126 New
MMG
1024
Monetary Management Group
Missouri
$1.35M -$31.6K -450 -2%
ACM
1025
AlphaCrest Capital Management
New York
$1.34M -$2.57M -36,607 -67%

CVS Hedge Fund Activity: Q4 2019 in Review

1,844 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2019, worth a combined $75.3B — up 18% from $63.9B a quarter earlier.

Buyers outnumbered sellers: 255 funds opened new CVS positions and 73 closed out — a net gain of 182 holders — while 723 added to existing stakes and 709 trimmed.

The largest buyer was Capital World Investors, adding an estimated $679M. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $418M.

  • 1,844 institutional investors held CVS Health (CVS) as of Q4 2019, up from 1,684 in Q3 2019.
  • Funds reported $75.3B of CVS Health stock for Q4 2019, up 18% quarter-over-quarter.
  • 255 funds opened new CVS Health positions in Q4 2019 and 73 closed out, a net change of +182 holders.
  • The largest CVS Health buyer in Q4 2019 was Capital World Investors, an estimated $679M added.
  • The largest CVS Health seller in Q4 2019 was Barrow, Hanley, Mewhinney & Strauss, an estimated $418M sold.

Based on aggregated 13F filings for Q4 2019.